Metabolomics Services Market: By Service (Separation and Detection, Bioinformatics Services), By Sample Type (Urine, Tumor, Cell Culture, Blood, Food Ingredients, Feces), By Sample Source (Human, Animal, Others), By End User (Healthcare Industry, Academic and Research Institutes, Food Processing Industry, and Others) and Geography.  

Purchase Option

$ 4400
$ 6600
$ 8900

Metabolomics Services Market size was valued at USD 111.5 million in 2022, growing at a CAGR of 12.5% from 2023-2029. The study and analysis of biochemical processes including metabolic intermediates and byproducts are known as metabolomics. Metabolomes are a phrase used to describe a collection of all metabolites engaged in various processes in an organism, including metabolic intermediates, signaling molecules, secondary metabolites, and hormones. By product segment, the largest market for metabolomics is metabolomics bioinformatics services and the segment is expected to expand at the highest CAGR throughout the projected period due to a large number of users of metabolomics analysis tools and services and the increasing need for data management. Moreover, players are focusing on acquisition for better growth in the market. For instance, in 2020, Danaher Corporation entered into a definitive agreement with General Electric Company to acquire the Biopharma business of GE Life Sciences. Some of the major factors that will likely accelerate the growth of the metabolomics services market in the projected timeframe are an increase in the number of patients suffering from neurological disorders, cancer, and cardiac diseases, increasing growth of the healthcare industry across the globe, increasing demand for personalized medicine, and an increase in the need for accurate disease diagnosis.

Metabolomics Services Market Key Developments:

In July 2021, Thermo Fisher Scientific, Inc. and the University of California, Davis (UC Davis) launched the Center of Excellence in Clinical Metabolomics, a research collaboration to provide innovations, best practices, and standard operating procedures to the metabolomics community.

 

Global Metabolomics Services Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

12.5%

Largest Market

Asia Pacific

Fastest Growing Market

North America
Metabolomics Services Market Dynamics

The market is expected to offer lucrative opportunities due to the increased prevalence of certain types of cancers across the globe. According to data released by the World Health Organization (WHO) in September 2021, approximately 70% of cancer deaths occurred in low- and middle-income countries throughout the world. Moreover, growing interest towards personalized medicines and identifying novel drug targets also immense boost to the market. For instance, according to a research study, in the United States, the percentage of patients for whom a drug is ineffective is high in case of cancer drugs (75%) and Alzheimer's drugs (70%). The top 10 highest grossing drugs help only up to 25% of the people who take them and the statins which are used to lower cholesterol only benefit 2% of the patients.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Metabolomics Services Market Segmentation

By Service Type
  • Separation & Detection Services
  • Bioinformatics Services

 

By Sample Type
  • Urine
  • Tumor
  • Cell Culture Media
  • Whole Blood
  • Food Ingredients
  • Feces
By Sample Source
  • Human
  • Animal
  • Others
By End User
  • Healthcare Industry
  • Academic & Research Institutes
  • Food Processing Industry
  • Others

Frequently Asked Questions

The metabolomics services market is projected to expand at a CAGR of 12.5% during the forecast period.

The major key players operating in the metabolomics services market are, Waters Corporation (US), Agilent Technologies (US), Shimadzu Corporation (Japan), Thermo Fisher Scientific (US), Danaher Corporation (US), Bruker Corporation (US), PerkinElmer (US), Merck KGaA (Germany), GE Healthcare (US), Hitachi High-Technologies Corporation (Japan), Human Metabolome Technologies, Inc. (Japan), LECO Corporation (US)

North America is the fastest-growing region for metabolomics services market

1. Executive Summary
2. Global Metabolomics Services Market Introduction
2.1. Global Metabolomics Services Market - Taxonomy
2.2. Global Metabolomics Services Market -Definitions
2.2.1. Service Type
2.2.2. Sample Type
2.2.3. Sample Source
2.2.4. End User
2.2.5. Region
3. Global Metabolomics Services  Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Collaborations, Acquisitions and Mergers
3.6. Global Metabolomics Services  Market - Competition Landscape
3.7. Global Metabolomics Services  Market Dynamic Factors - Impact Analysis
4. Global Metabolomics Services  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Metabolomics Services  Market, By Service Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1. Separation and Detection
5.1.1. Lipidomics
5.1.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Untargeted Metabolite Assays
5.1.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.1.3. Targeted Metabolite Assays
5.1.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3.3. Market Opportunity Analysis
5.2. Bioinformatics
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Metabolomics Services Market Forecast, By Sample Type, 2018 - 2022 and Forecast, 2023 - 2029
6.1. Urine
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Blood
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Tumor
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Cell Culture
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Food Ingredients
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Feces
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7. Market Opportunity Analysis Global Metabolomics Services Market Forecast, By Sample Source, 2018 - 2022 and Forecast, 2023 - 2029
7.1. Human
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Animal
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Metabolomics Services Market Forecast, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1. Healthcare Industry
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Academic and Research Institutes
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Food Processing Industry
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Others
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9. Global Metabolomics Services Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Metabolomics Services Market - Opportunity Analysis Index, By Service Type, By Sample Type, By Sample Source, By End User, and Region, 2023 - 2029
10. North America Metabolomics Services Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.1. Service Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Separation and Detection
10.1.1.1. Lipidomics
10.1.1.2. Untargeted Metabolite Assays
10.1.1.3. Targeted Metabolite Assays
10.1.2. Bioinformatics
10.2. Sample Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Urine
10.2.2. Blood
10.2.3. Tumor
10.2.4. Cell Culture
10.2.5. Food Ingredients
10.2.6. Feces
10.3. Sample Source Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Human
10.3.2. Animal
10.3.3. Others
10.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Healthcare Industry
10.4.2. Food Processing Industry
10.4.3. Academic Research Institutes
10.4.4. Others
10.5. Country Analysis 2016 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. U.S.
10.5.2. Canada
10.6. North America Metabolomics Services  Market - Opportunity Analysis Index, By Service Type, By Sample Type, By Sample Source, By End User, and Country, 2023 - 2029
10.7. North America Metabolomics Services  Market Dynamics - Trends
11. Europe Metabolomics Services  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
11.1. Service Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Separation and Detection
11.1.1.1. Lipidomics
11.1.1.2. Untargeted Metabolite Assays
11.1.1.3. Targeted Metabolite Assays
11.1.2. Bioinformatics
11.2. Sample Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Urine
11.2.2. Blood
11.2.3. Tumor
11.2.4. Cell Culture
11.2.5. Food Ingredients
11.2.6. Feces
11.3. Sample Source Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Human
11.3.2. Animal
11.3.3. Others
11.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Healthcare Industry
11.4.2. Food Processing Industry
11.4.3. Academic Research Institutes
11.4.4. Others
11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe Metabolomics Services Market - Opportunity Analysis Index, By Service Type, By Sample Type, By Sample Source, By End User, and Country, 2023 - 2029
11.7. Europe Metabolomics Services  Market Dynamics - Trends
12. Asia-Pacific Metabolomics Services  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
12.1. Service Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Separation and Detection
12.1.1.1. Lipidomics
12.1.1.2. Untargeted Metabolite Assays
12.1.1.3. Targeted Metabolite Assays
12.1.2. Bioinformatics
12.2. Sample Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Urine
12.2.2. Blood
12.2.3. Tumor
12.2.4. Cell Culture
12.2.5. Food Ingredients
12.2.6. Feces
12.3. Sample Source Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Human
12.3.2. Animal
12.3.3. Others
12.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Healthcare Industry
12.4.2. Food Processing Industry
12.4.3. Academic Research Institutes
12.4.4. Others
12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Metabolomics Services  Market - Opportunity Analysis Index, By Service Type, By Sample Type, By Sample Source, By End User, and Country, 2023 - 2029
12.7. Asia-Pacific Metabolomics Services  Market Dynamics - Trends
13. Latin America Metabolomics Services  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.1. Service Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Separation and Detection
13.1.1.1. Lipidomics
13.1.1.2. Untargeted Metabolite Assays
13.1.1.3. Targeted Metabolite Assays
13.1.2. Bioinformatics
13.2. Sample Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Urine
13.2.2. Blood
13.2.3. Tumor
13.2.4. Cell Culture
13.2.5. Food Ingredients
13.2.6. Feces
13.3. Sample Source Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Human
13.3.2. Animal
13.3.3. Others
13.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Healthcare Industry
13.4.2. Food Processing Industry
13.4.3. Academic Research Institutes
13.4.4. Others
13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Metabolomics Services  Market - Opportunity Analysis Index, By Service Type, By Sample Type, By Sample Source, By End User, and Country, 2023 - 2029
13.7. Latin America Metabolomics Services  Market Dynamics - Trends
14. Middle East and Africa Metabolomics Services  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.1. Service Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Separation and Detection
14.1.1.1. Lipidomics
14.1.1.2. Untargeted Metabolite Assays
14.1.1.3. Targeted Metabolite Assays
14.1.2. Bioinformatics
14.2. Sample Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Urine
14.2.2. Blood
14.2.3. Tumor
14.2.4. Cell Culture
14.2.5. Food Ingredients
14.2.6. Feces
14.3. Sample Source Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Human
14.3.2. Animal
14.3.3. Others
14.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Healthcare Industry
14.4.2. Food Processing Industry
14.4.3. Academic Research Institutes
14.4.4. Others
14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Metabolomics Services  Market - Opportunity Analysis Index, By Service Type, By Sample Type, By Sample Source, By End User, and Country, 2023 - 2029
14.7. MEA Metabolomics Services  Market Dynamics - Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Owl Metabolomics. (Spain),
15.2.2. Metabolon, Inc. (U.S.),
15.2.3. Metanomics health (Germany)
15.2.4. Creative Untargeted Metabolite Analysis (U.S.),
15.2.5. SteminaBiomarker Discovery, Inc. (U.S.),
15.2.6. TMIC (Canada)
15.2.7. West Coast Metabolomics Center (U.S.)
15.2.8. Lipotype GmbH. (Germany)
15.2.9. Chenomx Inc. (Canada)
16. Research Methodology
17. Key Assumptions and Acronyms
  • Waters Corporation (US)
  • Agilent Technologies (US)
  • Shimadzu Corporation (Japan)
  • Thermo Fisher Scientific (US)
  • Danaher Corporation (US)
  • Bruker Corporation (US)
  • PerkinElmer (US)
  • Merck KGaA (Germany)
  • GE Healthcare (US)
  • Hitachi High-Technologies Corporation (Japan)
  • Human Metabolome Technologies, Inc. (Japan),
  • LECO Corporation (US)

Adjacent Markets